|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-11-13
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The aim of this substudy within a prospective, multicenter, placebo-controlled trial was to assess the pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on comedication with mycophenolate mofetil (MMF).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-15,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Mycophenolic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/basiliximab,
http://linkedlifedata.com/resource/pubmed/chemical/mycophenolate mofetil
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1534-6080
|
|
pubmed:author |
pubmed-author:DanielVolkerV,
pubmed-author:FehrenbachHenryH,
pubmed-author:HöckerBrittaB,
pubmed-author:HolderMartinM,
pubmed-author:HoppeBerndB,
pubmed-author:HoyerPeterP,
pubmed-author:JungraithmayrTherese CTC,
pubmed-author:Köpf-ShakibSabineS,
pubmed-author:KovarikJohn MJM,
pubmed-author:LaubeGuido FGF,
pubmed-author:Müller-WiefelDirk EDE,
pubmed-author:OffnerGiselaG,
pubmed-author:OpelzGerhardG,
pubmed-author:PlankChristianC,
pubmed-author:SchröderMonikaM,
pubmed-author:TönshoffBurkhardB,
pubmed-author:WeberLutz TLT,
pubmed-author:ZimmerhacklLothar BLB
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1234-40
|
|
pubmed:meshHeading |
pubmed-meshheading:19005405-Adolescent,
pubmed-meshheading:19005405-Aging,
pubmed-meshheading:19005405-Antibodies, Monoclonal,
pubmed-meshheading:19005405-Child,
pubmed-meshheading:19005405-Child, Preschool,
pubmed-meshheading:19005405-Dose-Response Relationship, Drug,
pubmed-meshheading:19005405-Double-Blind Method,
pubmed-meshheading:19005405-Drug Therapy, Combination,
pubmed-meshheading:19005405-Humans,
pubmed-meshheading:19005405-Immunophenotyping,
pubmed-meshheading:19005405-Immunosuppressive Agents,
pubmed-meshheading:19005405-Interleukin-15,
pubmed-meshheading:19005405-Interleukin-2,
pubmed-meshheading:19005405-Kidney Transplantation,
pubmed-meshheading:19005405-Mycophenolic Acid,
pubmed-meshheading:19005405-Prospective Studies,
pubmed-meshheading:19005405-Receptors, Interleukin-2,
pubmed-meshheading:19005405-Recombinant Fusion Proteins,
pubmed-meshheading:19005405-Signal Transduction
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.
|
|
pubmed:affiliation |
Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
